Skip to content
10-Q

Quarterly Report

ProLung, Inc.

0001493152-21-020244

← back to feed
Filed
Aug 16, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2021 · Aug 16, 2021 4.12M sh
Cash And Equivalents Q2 2021 · Jun 30, 2021 $1.57M
Cash And Equivalents Q2 2021 · Dec 31, 2020 $185.13K
Current Liabilities Q2 2021 · Jun 30, 2021 $11.81M
Current Liabilities Q2 2021 · Dec 31, 2020 $1.73M
Total Liabilities Q2 2021 · Jun 30, 2021 $11.81M
Total Liabilities Q2 2021 · Dec 31, 2020 $9.23M
Current Assets Q2 2021 · Jun 30, 2021 $1.57M
Current Assets Q2 2021 · Dec 31, 2020 $190.55K
Total Assets Q2 2021 · Jun 30, 2021 $1.74M
Total Assets Q2 2021 · Dec 31, 2020 $389.2K
Short Term Debt Q2 2021 · Dec 31, 2020 $105K
Capex Q2 2021 · Jun 30, 2020 $3.59K
Operating Cash Flow Q2 2021 · Jun 30, 2020 −$1.15M
Stockholders Equity Q2 2021 · Jun 30, 2020 −$7.76M
Stockholders Equity Q2 2021 · Mar 31, 2020 −$7.18M
Stockholders Equity Q2 2021 · Dec 31, 2019 −$6.7M
Sga Expense Q2 2021 · Jun 30, 2020 $431.03K
Sga Expense Q2 2021 · Jun 30, 2020 $810.17K
Rd Expense Q2 2021 · Jun 30, 2020 $198.29K
Rd Expense Q2 2021 · Jun 30, 2020 $389.94K
Net Income Q2 2021 · Jun 30, 2020 −$806.74K
Net Income Q2 2021 · Jun 30, 2020 −$1.52M
Net Income Q2 2021 · Mar 31, 2020 −$712.88K
Operating Income Q2 2021 · Jun 30, 2020 −$629.32K
Operating Income Q2 2021 · Jun 30, 2020 −$1.2M